Colorant adding technology applied to medical active pulvis, and uniformly-colorized medical active pulvis
A uniform dyeing and dyeing agent technology, applied in the field of medical active powder, can solve the problems of increased dyeing agent, uneven distribution of dyeing agent, and difficulty in ensuring the uniformity of dyeing agent distribution.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] This embodiment provides a uniformly dyed medical active powder, specifically uniformly dyed polylactic acid powder, which is prepared according to the following coloring agent addition process:
[0046] Weigh 10g of polylactic acid (PLA, weight average molecular weight 70KD) as a medical active powder and dissolve it in 100g of toluene (the first good solvent) to prepare a medical active powder solution.
[0047] Weigh 0.005g of β-carotene (medical dye) and dissolve it in 0.5g of chloroform (the second good solvent) to prepare a medical dye solution.
[0048] Mix the two solutions of the medical active powder solution and the medical dye solution, and stir evenly to form a mixed solution.
[0049] Transfer the mixed solution to a one-necked bottle, connect it to a rotary evaporator, turn on the vacuum system and the low-temperature cooling circulation system, and concentrate by rotary evaporation at 25±5°C.
[0050] When the remaining liquid in the one-necked bottle i...
Embodiment 2
[0053] This embodiment provides a uniformly dyed medical active powder, specifically a uniformly dyed two-arm polyethylene glycol-thiol powder, which is prepared according to the following coloring agent addition process:
[0054] Weigh 10g of two-arm polyethylene glycol-thiol (2-arm-PEG-SH, weight-average molecular weight 10KD) and dissolve it in 120g n-butanol (the first good solvent) as a medical active powder, and reinforce it with 0.22 μm nylon Membrane filtration, prepared into medical active powder solution.
[0055] Weigh 0.002g of butyl hydroxyanisole (BHA) as the medical active powder and dissolve it in 10g of ethanol (the first good solvent) to obtain the second medical active powder solution.
[0056] Weigh 0.015g of bright green (medical dye) and dissolve it in 5g of propylene glycol (the second good solvent), filter it with a 0.22 μm nylon reinforced filter membrane, and prepare a medical dye solution.
[0057] Mix the medical active powder solution and the medi...
Embodiment 3
[0062] This embodiment provides a uniformly dyed medical active powder, specifically a uniformly dyed four-armed polyethylene glycol-N-hydroxysuccinimide-glutarate powder, which is prepared according to the following dyeing process:
[0063] Four-arm polyethylene glycol-N-hydroxysuccinimide-glutarate (4-arm-PEG-SG, weight-average molecular weight 20KD) was weighed to prepare a medical active powder solution.
[0064] Weigh 0.01g of Brilliant Blue as a medical dye and dissolve it in 5g of ethanol (the second good solvent) to prepare a medical dye solution.
[0065] The two solutions were mixed and transferred to a one-necked bottle, connected to a rotary evaporator, turned on the vacuum system and low-temperature cooling circulation system, and concentrated by rotary evaporation at 25±5°C.
[0066] When the remaining liquid in the one-necked bottle is about 8% of the volume of the original mixed solution, add 150 g of anhydrous ether (poor solvent) under stirring, and continue ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

